HCA Healthcare (NYSE:HCA) Receives Overweight Rating from Cantor Fitzgerald

HCA Healthcare (NYSE:HCA)‘s stock had its “overweight” rating reiterated by stock analysts at Cantor Fitzgerald in a report issued on Monday, Benzinga reports. They currently have a $392.00 price objective on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 4.56% from the company’s previous close.

HCA has been the subject of a number of other research reports. UBS Group increased their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Robert W. Baird initiated coverage on HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target for the company. Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday. Finally, Barclays lifted their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $354.67.

HCA Healthcare Trading Up 0.3 %

HCA stock traded up $1.14 on Monday, reaching $374.91. The company’s stock had a trading volume of 131,487 shares, compared to its average volume of 1,142,079. The business has a fifty day simple moving average of $340.45 and a two-hundred day simple moving average of $328.69. HCA Healthcare has a 12-month low of $215.96 and a 12-month high of $375.64. The firm has a market cap of $98.19 billion, a PE ratio of 18.72, a PEG ratio of 1.39 and a beta of 1.68. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the firm posted $4.29 earnings per share. As a group, research analysts forecast that HCA Healthcare will post 22.43 EPS for the current year.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders sold a total of 8,844 shares of company stock valued at $3,185,932 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several large investors have recently added to or reduced their stakes in HCA. Atlantic Edge Private Wealth Management LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at about $27,000. Bangor Savings Bank raised its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare in the 2nd quarter worth about $28,000. Finally, GPS Wealth Strategies Group LLC raised its holdings in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.